167 related articles for article (PubMed ID: 19998683)
21. Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study.
Kotterba S; Neusser T; Norenberg C; Bussfeld P; Glaser T; Dörner M; Schürks M
BMC Neurol; 2018 Aug; 18(1):123. PubMed ID: 30143019
[TBL] [Abstract][Full Text] [Related]
22. Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
Nygaard GO; Walhovd KB; Sowa P; Chepkoech JL; Bjørnerud A; Due-Tønnessen P; Landrø NI; Damangir S; Spulber G; Storsve AB; Beyer MK; Fjell AM; Celius EG; Harbo HF
Mult Scler; 2015 Apr; 21(4):402-14. PubMed ID: 25139946
[TBL] [Abstract][Full Text] [Related]
23. Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis.
Bartnik P; Wielgoś A; Kacperczyk J; Pisarz K; Szymusik I; Podlecka-Piętowska A; Zakrzewska-Pniewska B; Wielgoś M
Brain Behav; 2017 Jun; 7(6):e00699. PubMed ID: 28638707
[TBL] [Abstract][Full Text] [Related]
24. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
[TBL] [Abstract][Full Text] [Related]
25. Quality of life assessment in migraine and relapsing remitting multiple sclerosis: self-perceived health is similar.
Glavor KD; Titlić M; Vuletić G; Mrđen A; Šimunić MM
Neurol Sci; 2019 Dec; 40(12):2549-2554. PubMed ID: 31317351
[TBL] [Abstract][Full Text] [Related]
26. Tracking daily fatigue fluctuations in multiple sclerosis: ecological momentary assessment provides unique insights.
Powell DJH; Liossi C; Schlotz W; Moss-Morris R
J Behav Med; 2017 Oct; 40(5):772-783. PubMed ID: 28281106
[TBL] [Abstract][Full Text] [Related]
27. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
28. The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?
Barin L; Salmen A; Disanto G; Babačić H; Calabrese P; Chan A; Kamm CP; Kesselring J; Kuhle J; Gobbi C; Pot C; Puhan MA; von Wyl V;
Mult Scler Relat Disord; 2018 Oct; 25():112-121. PubMed ID: 30059895
[TBL] [Abstract][Full Text] [Related]
29. The effects of modified anti-inflammatory diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: a randomized clinical trial.
Mousavi-Shirazi-Fard Z; Mazloom Z; Izadi S; Fararouei M
Int J Neurosci; 2021 Jul; 131(7):657-665. PubMed ID: 32249637
[TBL] [Abstract][Full Text] [Related]
30. Pain Intensity and Pain Interference in People With Progressive Multiple Sclerosis Compared With People With Relapsing-Remitting Multiple Sclerosis.
Knowles LM; Phillips KM; Herring TE; Alschuler KN; Jensen MP; Turner AP; Ehde DM
Arch Phys Med Rehabil; 2021 Oct; 102(10):1959-1964. PubMed ID: 34048792
[TBL] [Abstract][Full Text] [Related]
31. Physical and psychological variables that influence pain in patients with fibromyalgia.
Hughes L
Orthop Nurs; 2006; 25(2):112-9; quiz 120-1. PubMed ID: 16572028
[TBL] [Abstract][Full Text] [Related]
32. Features of sleep disturbances in multiple sclerosis patients.
Leonavicius R; Adomaitiene V
Psychiatr Danub; 2014 Sep; 26(3):249-55. PubMed ID: 25191772
[TBL] [Abstract][Full Text] [Related]
33. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.
Janardhan V; Bakshi R
J Neurol Sci; 2002 Dec; 205(1):51-8. PubMed ID: 12409184
[TBL] [Abstract][Full Text] [Related]
34. Selective Cerebellar Atrophy Associates with Depression and Fatigue in the Early Phases of Relapse-Onset Multiple Sclerosis.
Lazzarotto A; Margoni M; Franciotta S; Zywicki S; Riccardi A; Poggiali D; Anglani M; Gallo P
Cerebellum; 2020 Apr; 19(2):192-200. PubMed ID: 31898280
[TBL] [Abstract][Full Text] [Related]
35. Memory performance in multiple sclerosis patients correlates with central brain atrophy.
Hildebrandt H; Hahn HK; Kraus JA; Schulte-Herbrüggen A; Schwarze B; Schwendemann G
Mult Scler; 2006 Aug; 12(4):428-36. PubMed ID: 16900756
[TBL] [Abstract][Full Text] [Related]
36. Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Sundgren M; Wahlin Å; Maurex L; Brismar T
J Neurol Sci; 2015 Sep; 356(1-2):107-12. PubMed ID: 26117361
[TBL] [Abstract][Full Text] [Related]
37. Effects of change in fatigue and depression on physical activity over time in relapsing-remitting multiple sclerosis.
Motl RW; McAuley E; Wynn D; Suh Y; Weikert M
Psychol Health Med; 2011 Jan; 16(1):1-11. PubMed ID: 21218359
[TBL] [Abstract][Full Text] [Related]
38. Interrelationships among common symptoms in the elderly and their effects on health-related quality of life: a cross-sectional study in rural Korea.
Mun S; Park K; Baek Y; Lee S; Yoo JH
Health Qual Life Outcomes; 2016 Oct; 14(1):146. PubMed ID: 27733204
[TBL] [Abstract][Full Text] [Related]
39. Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis.
Braga DM; Prado GF; Bichueti DB; Oliveira EM
Arq Neuropsiquiatr; 2016 Jun; 74(6):433-8. PubMed ID: 27332066
[TBL] [Abstract][Full Text] [Related]
40. Is the association between health-related quality of life and fatigue mediated by depression in patients with multiple sclerosis? A Spanish cross-sectional study.
Fernández-Muñoz JJ; Cigarán-Méndez M; Navarro-Pardo E; Pérez-de-Heredia-Torres M; Parás-Bravo P; Fernández-de-Las-Peñas C
BMJ Open; 2018 Jan; 8(1):e016297. PubMed ID: 29362245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
